Athletes understand their bodies. They know the difference between soreness that fades and structural damage that doesn’t. When something is genuinely wrong — a shoulder that won’t settle, a knee that buckles at the wrong moment, a tendon that keeps flaring — they want real answers, not another round of rest and anti-inflammatories.
Orthobiologics have become a significant part of how professional and high-level athletes manage injuries, and not just as a last resort before surgery. PRP and BMAC are increasingly used proactively — to accelerate recovery, reduce downtime, and extend careers.
Why Athletes Are Turning to Biologics
Traditional injury management for soft tissue damage relies heavily on rest, physical therapy, NSAIDs, and — when those aren’t enough — surgery. Surgery, even when successful, involves weeks to months of recovery and the physiological cost of an operated joint. For a professional athlete, that cost is measured not just in calendar time but in form, conditioning, and competitive readiness.
Orthobiologics offer a different pathway. By delivering concentrated healing agents directly to the site of injury, they can accelerate the repair of tendons, ligaments, and joint structures in ways that passive rest simply cannot replicate. For many injuries, this shortens return-to-play timelines meaningfully.
The Injuries Orthobiologics Address
Tendon injuries. Patellar tendinopathy, Achilles tendinopathy, rotator cuff tendinosis — these are among the most common and most frustrating injuries in competitive sports. Tendons are slow to heal because they receive limited blood supply. PRP directly addresses this limitation by flooding the tendon with concentrated growth factors. Clinical data consistently supports PRP for tendinopathy across multiple sports.
Partial ligament tears. For athletes with partial ACL, MCL, or ankle ligament tears that don’t require surgical reconstruction, PRP can meaningfully support tissue repair and help stabilize the joint during rehabilitation.
Meniscal pathology. The meniscus has poor intrinsic healing capacity, particularly in its inner two-thirds. PRP and BMAC can support the healing environment for partial or degenerative meniscal tears, sometimes making it possible to avoid or defer meniscectomy.
Rotator cuff injuries. Partial thickness rotator cuff tears are extremely common in throwing athletes, overhead athletes, and racquet sports players. PRP is increasingly used as a first-line biologic intervention before considering surgical repair.
Labral tears. Hip and shoulder labral pathology responds to BMAC therapy in appropriate candidates, particularly when the tear is partial and the anatomy is otherwise preserved.
Dr. Scheinberg and Elite Tennis
Dr. Scheinberg’s involvement with professional athletes is extensive. He has treated some of the most notable names in world tennis — including Jimmy Connors, Andre Agassi, Maria Sharapova, Lindsay Davenport, and Patrick Rafter. He also serves as a medical consultant for the International Management Group (IMG), which represents and manages some of the world’s top professional athletes.
His work with Jimmy Connors is illustrative. Dr. Scheinberg performed surgery on Connors’ wrist, and six months later Connors reached the semifinals of the US Open — at age 39. That level of outcome requires not just technical skill but a deep understanding of what an athlete needs to return to peak performance.
That same philosophy applies to his orthobiologic work. When an athlete comes to the Scheinberg Clinic in Santa Barbara, Dr. Scheinberg brings a surgical understanding of the injury alongside a genuine appreciation of what return to play means to that individual. The protocol is designed not just to reduce pain but to restore function.
Orthobiologics vs. Surgery for Athletic Injuries
The comparison is not always straightforward. There are injuries that require surgery — complete tendon ruptures, full-thickness ACL tears with functional instability, displaced fractures. Dr. Scheinberg knows those cases well.
But there is a large and important middle ground of injuries where surgery is commonly recommended before biologic options have been genuinely explored. For athletes in this zone, the conversation Dr. Scheinberg offers is different from what they might hear elsewhere: What does your imaging actually show? What is the realistic recovery timeline for surgery versus biologics? What are you risking if you try biologics first?
That conversation — honest, surgical-grade, and driven by decades of real-world outcome experience — is what brings athletes from throughout California and beyond to the Santa Barbara clinic.